treatment

Oral Azacitidine Improves, Sustains Health-Related QoL in AML

Original Publication Date
Article Source
External Web Content
Treatment with the oral agent showed sustained health-related quality of life compared with placebo in patients with acute myeloid leukemia, according to results of the phase 3 QUAZAR AML-001 trial. Treatment with oral azacitidine (CC-486) showed sustained health-related quality…

Beat AML Master Clinical Trial Showcases Paradigm Shift With Precision Medicine

Original Publication Date
Article Source
External Web Content
Delaying treatment for up to 7 days so that genomic data can be utilized to inform a personalized treatment approach is safe, feasible, and can improve overall survival in patients with acute myeloid leukemia. John C. Byrd, MD Delaying treatment for up to 7 days so that genomic…

Guang-Shing Cheng, M.D.

Institution
Fred Hutchinson Cancer Research Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Graft Versus Host Disease (GVHD)
About
Dr. Guang-Shing Cheng is Associate Professor in the Clinical Research Division at Fred Hutch in Seattle. Dr. Cheng is a pulmonologist who focuses on improving outcomes for cancer patients who have respiratory failure and lung complications related to their cancer treatments. She is developing new ways to prevent lung damage and improve lung function in these patients. Dr. Cheng’s main interest is bronchiolitis obliterans syndrome, a serious complication of blood stem cell transplantation. She also studies the role of respiratory viruses and other infectious pathogens in lung disease in

Staci Arnold, MD, MBA, MPH

Institution
Children's Healthcare of Atlanta
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric
About
Dr. Arnold is an Assistant Professor of Pediatrics, Emory University School of Medicine. She specializes in pediatric hematology and has particular expertise in the care of children undergoing stem cell transplantation for noncancerous disorders, such as sickle cell anemia, aplastic anemia and thalassemia. In addition to caring for patients, Dr. Arnold conducts research. She has an MBA and does outcome research to demonstrate the cost-effectiveness of the therapies she uses.

Treatment Approaches in AML: Key Testing for Personalized Care

Original Publication Date
Article Source
External Web Content
VIDEO Description: Treatment Approaches in AML: Key Testing for Personalized Care from Patient Empowerment Network on Vimeo. When it comes to Acute Myeloid Leukemia (AML), genetic testing (or biomarker testing) is essential in helping to determine the best treatment approach for…

Talati Highlights “Game-Changing” Potential of Venetoclax/HMA Combos for Elderly AML

Original Publication Date
Article Source
External Web Content
Chetasi Talati, MD, discusses early results from a multicenter chart review examining treatment patterns and outcomes of patients with newly diagnosed AML who received venetoclax/HMA combinations in the real-world setting and the next phase of the ongoing research initiative…

ASH Issues Guidelines on Newly Diagnosed AML in Older Adults

Original Publication Date
Article Source
External Web Content
In evidence-based guidelines issued by the American Society of Hematology and published in the Aug. 11 issue of Blood Advances, recommendations are presented for the management of newly diagnosed acute myeloid leukemia (AML) in older adults. Mikkael A. Sekeres, M.D., from the…
Subscribe to treatment

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.